Cycle Pharmaceuticals announced the launch of HARLIKU, the first and only FDA-approved treatment for reducing urinary ...

Presentations highlight clinically meaningful reductions in BMI in patients with acquired hypothalamic obesity – - Full data ...

Abbott is doubling down on the structural heart space, as it aims to gain ground in valve replacements following the recent ...

Tobin Scientific, a provider of cGMP-compliant warehousing and transportation solutions, has opened its newest cGMP warehouse ...

The project marks a significant step forward in addressing the critical need for purpose-built life sciences manufacturing ...

As Azurity Pharmaceuticals rethinks its manufacturing footprint, the privately held company is parting ways with a clutch of ...

The study included 12 patients who suffer from a subset of Type 1 diabetes known as hypoglycemic unawareness, characterized ...

Health care stocks have outperformed so far in 2025 despite uncertainty surrounding the Donald Trump administration's policies. Health care stocks can often be a solid defensive play in an ...

Asia-Pacific Emerges as the New Powerhouse in Nonwoven Filter Media Market Amidst Accelerated Industrialization, Urban Expansion, and Manufa ...

This randomized, double-masked, placebo-controlled, Phase 2 Proof-of-Concept trial of urcosimod to treat NCP was conducted at a single trial site at Tufts Medical Center in Boston, MA, with Pedram ...

Bain Capital and Kohlberg have completed a strategic investment in PCI Pharma Services, according to a news release.